Results 21 to 30 of about 8,760,079 (149)

Clinical manifestations of gastrointestinal form of food allergy in children and approaches to its diagnosis

Zdorovʹe Rebenka, 2017
Gastrointestinal food allergy is caused by the development of allergic inflammation in the mucosa of the gastrointestinal tract. The mechanisms of this inflammation are immunogflobulin E (IgE)-mediated (oral allergic syndrome, immediate gastrointestinal ...
Yu.R. Chernysh, O.M. Okhotnikova
doaj   +1 more source

Protein-bound veterinary drug residues in food [PDF]

, 1999
End of Project ReportBound residues of veterinary drugs have been recognised as an important aspect of food safety particularly (a) where such residues may persist for long periods after withdrawal of the drug treatment and (b) where the bound residues ...
Cadogan, Aodhmar, Coyle, Tiernan, O'Keeffe, Michael, Horne, Elizabeth   +3 more
core   +1 more source

Epizootic rabbit enteropathy. Study of early phenomena with fresh inoculum and attempt at inactivation [PDF]

, 2005
[EN] Using 180 35-day-old SPF rabbits, this study used the effectiveness of bacitracin as a tool for acquiring more information on the various phases of ERE, in particular during the hours inoculation.
Coudert, P., Licois, D.
core   +1 more source

Perspectives on Non-IgE-Mediated Gastrointestinal Food Allergy in Pediatrics: A Review of Current Evidence and Guidelines

Journal of Asthma and Allergy, 2023
Montaha AL-Iede,1 Lena Sarhan,2 Mohammad A Alshrouf,2 Yazan Said3 1Division of Pediatric Pulmonology and Sleep Medicine, Department of Pediatrics, Jordan University Hospital, Amman, Jordan; 2Department of Pediatrics, Jordan University Hospital, The ...
AL-Iede M, Sarhan L, Alshrouf MA, Said Y
doaj  

Current Trends in Tolerance Induction in Cow's Milk Allergy: From Passive to Proactive Strategies

Frontiers in Pediatrics, 2019
This review addresses the current strategies of inducing tolerance development in infant and childhood cow's milk protein allergy (CMPA). The change in prevention strategies for CMPA has been emphasized based on the lack of evidence to support the ...
Cansin Sackesen, Derya Ufuk Altintas, Aysen Bingol, Gulbin Bingol, Betul Buyuktiryaki, Esen Demir, Aydan Kansu, Zarife Kuloglu, Zeynep Tamay, Bulent Enis Sekerel   +9 more
doaj   +1 more source

Protein-losing enteropathy

, 2020
Purpose of reviewThe present review offers its readers a practical overview of protein-losing enteropathy, particularly with regard to diagnostic and therapeutic approaches.
Rimondi A., Elli L., Topa M.
core   +1 more source

Signaling of angiotensin II-induced vascular protein synthesis in conduit and resistance arteries in vivo [PDF]

, 2004
<b>Background</b> From in vitro studies, it has become clear that several signaling cascades are involved in angiotensin II-induced cellular hypertrophy.
Martens Fabrice MAC, Fabrice MAC Martens, Touyz, R.M., Daigle, Christine, Martens, Fabrice, Touyz Rhian M, Dao Huy, Christine Daigle, Huy Hao Dao, Daphné Girardot, Rhian M Touyz, Moreau Pierre, Girardot, D., Daigle, C., Dao, H., Moreau, P., Girardot, Daphné, Martens, F.M.A.C., Dao, Huy, Daigle Christine, Moreau, Pierre, Girardot Daphné, Pierre Moreau, Touyz, Rhian   +23 more
core   +2 more sources

Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey

The Turkish Journal of Pediatrics, 2016
The present paper aims to provide experts' consensus on diagnosis and management of cow's milk protein allergy (CMPA) among infants and children in Turkey, based on review of available evidence-based guidelines, publications and experts' clinical ...
Aydan Kansu, Aysel Yüce, Buket Dalgıç, Bülent Enis Şekerel, Fügen Çullu-Çokuğraş, Haluk Çokuğraş   +5 more
doaj   +1 more source

Protein-losing enteropathy after the Fontan operation [PDF]

, 1996
Patients were observed after the Fontan operation to determine the frequency and severity of protein-losing enteropathy. A total of 427 patients who survived for 30 days after the Fontan operation, performed between 1973 and January 1987, were analyzed ...
Offord, Kenneth P., Ruth H. Cha, Gordon K. Danielson, Jean Perrault, Cha, Ruth H., Schaff, Hartzell V., Feldt, Robert H., Puga, Francisco J., David J. Driscoll, Hartzell V. Schaff, Francisco J. Puga, Perrault, Jean, Robert H. Feldt, Kenneth P. Offord, Danielson, Gordon K., Driscoll, David J.   +15 more
core   +1 more source

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

JPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan, Christian Wysocki, Bhaskar Gurram   +2 more
wiley   +1 more source